Clinical trial
Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy
NCT00447070 is registered in ClinicalTrials.gov with Foundation for Cardiovascular Research, Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy
- Lead sponsor
- Foundation for Cardiovascular Research, Zurich
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2004
- Completion date
- May 31, 2006
- Enrollment
- 50
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dyslipidemia, hiv infections